Uses multimodal PET and MRI to characterize preclinical Alzheimer's disease in cognitively unimpaired older adults. Integrates amyloid, tau, structural and functional imaging, genetics, and longitudinal cognition to estimate individual risk and support prevention trials before widespread neuronal damage.